Wolf G - Search Results

1

Interaction between the Grb10 SH2 domain and the insulin receptor carboxyl terminus.

Hansen H, Svensson U, Zhu J, Laviola L, Giorgino F, Wolf G, Smith RJ, Riedel H. Hansen H, et al. Among authors: wolf g. J Biol Chem. 1996 Apr 12;271(15):8882-6. doi: 10.1074/jbc.271.15.8882. J Biol Chem. 1996. PMID: 8621530 Free article.

2

SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.

Case RD, Piccione E, Wolf G, Benett AM, Lechleider RJ, Neel BG, Shoelson SE. Case RD, et al. Among authors: wolf g. J Biol Chem. 1994 Apr 8;269(14):10467-74. J Biol Chem. 1994. PMID: 8144631 Free article.

3

PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities.

Wolf G, Trüb T, Ottinger E, Groninga L, Lynch A, White MF, Miyazaki M, Lee J, Shoelson SE. Wolf G, et al. J Biol Chem. 1995 Nov 17;270(46):27407-10. doi: 10.1074/jbc.270.46.27407. J Biol Chem. 1995. PMID: 7499194 Free article.

4

Specificity of the PTB domain of Shc for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine.

Trüb T, Choi WE, Wolf G, Ottinger E, Chen Y, Weiss M, Shoelson SE. Trüb T, et al. Among authors: wolf g. J Biol Chem. 1995 Aug 4;270(31):18205-8. doi: 10.1074/jbc.270.31.18205. J Biol Chem. 1995. PMID: 7543098 Free article.

5

Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking.

Giorgetti-Peraldi S, Ottinger E, Wolf G, Ye B, Burke TR Jr, Shoelson SE. Giorgetti-Peraldi S, et al. Among authors: wolf g. Mol Cell Biol. 1997 Mar;17(3):1180-8. doi: 10.1128/MCB.17.3.1180. Mol Cell Biol. 1997. PMID: 9032245 Free PMC article.

6

Tyrosine-phosphorylated Cbl binds to Crk after T cell activation.

Sawasdikosol S, Chang JH, Pratt JC, Wolf G, Shoelson SE, Burakoff SJ. Sawasdikosol S, et al. Among authors: wolf g. J Immunol. 1996 Jul 1;157(1):110-6. J Immunol. 1996. PMID: 8683103

7

4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides.

Burke TR Jr, Ye B, Akamatsu M, Ford H Jr, Yan X, Kole HK, Wolf G, Shoelson SE, Roller PP. Burke TR Jr, et al. Among authors: wolf g. J Med Chem. 1996 Mar 1;39(5):1021-7. doi: 10.1021/jm950621g. J Med Chem. 1996. PMID: 8676336

8

Correlation between binding and dynamics at SH2 domain interfaces.

Kay LE, Muhandiram DR, Wolf G, Shoelson SE, Forman-Kay JD. Kay LE, et al. Among authors: wolf g. Nat Struct Biol. 1998 Feb;5(2):156-63. doi: 10.1038/nsb0298-156. Nat Struct Biol. 1998. PMID: 9461082

9

L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.

Ye B, Akamatsu M, Shoelson SE, Wolf G, Giorgetti-Peraldi S, Yan X, Roller PP, Burke TR Jr. Ye B, et al. Among authors: wolf g. J Med Chem. 1995 Oct 13;38(21):4270-5. doi: 10.1021/jm00021a016. J Med Chem. 1995. PMID: 7473554

10

Conformationally constrained phosphotyrosyl mimetics designed as monomeric Src homology 2 domain inhibitors.

Burke TR Jr, Barchi JJ Jr, George C, Wolf G, Shoelson SE, Yan X. Burke TR Jr, et al. Among authors: wolf g. J Med Chem. 1995 Apr 14;38(8):1386-96. doi: 10.1021/jm00008a017. J Med Chem. 1995. PMID: 7537333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,583 results

Search Page

Filters